Bionic eye implant aims to bring back sight in advanced macular degeneration

NCT ID NCT04676854

Ongoing Disease control Sponsor: Science Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a device called the PRIMA System, which includes an implant placed under the retina and a special visual processor worn by the patient. The goal is to help people with advanced dry age-related macular degeneration (geographic atrophy) regain some central vision. Thirty-eight participants aged 60 and older with severe vision loss in both eyes will be implanted and followed for up to 6 years to see if their vision improves and to monitor for any side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATROPHIC AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry age related macular degeneration Geographic Atrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GEOGRAPHIC ATROPHY

Contacts and locations

Locations

Augenklinik der Ludwig-Maximilian Universität München

Munich, 80336, Germany
CHU de Nantes

Nantes, 44093, France
Centre Monticelli Paradis

Marseille, 13008, France
Centre hospitalier intercommunal de Créteil - Service Ophtalmologie

Créteil, 94000, France
Fondation Ophtalmologique A. De Rothschild

Paris, 75019, France
Hopital des Quinze Vingts

Paris, 75012, France
Hôpital Pellegrin

Bordeaux, 33000, France
Hôpital de la Croix-Rousse CHU de LYON

Lyon, Lyon, 69004, France
Instituto de Microcirugía Ocular de Barcelona

Barcelona, 08035, Spain
KNAPPSCHAFTSKLINIKUM SAAR GMBH Augenklinik Sulzbach

Sulzbach, 66280, Germany
Klinikum Ludwigshafen -Augenklinik

Ludwigshafen am Rhein, 67063, Germany
Moorfields Eye Hospital NHS Foundation Trust

London, 0207 566 2117, United Kingdom
Rotterdam Eye Hospital

Rotterdam, 3011 BH, Netherlands
Università di Roma Tor Vergata - Policlinico Tor Vergata (PTV), Dipartimento di Medicina Sperimentale - Oftalmologia

Roma, 00133, Italy
Universitäts-Augenklinik Bonn

Bonn, 53127, Germany
Universitäts-Augenklinik Münster

Münster, 48149, Germany
Universitätsklinikum Aachen, Klinik fuer Augenheilkunde

Aachen, 52074, Germany
Universitätsklinikum Hamburg-Eppendorf (UKE), Augenklinik

Hamburg, 20251, Germany
Universitätsklinikum Schleswig-Holstein Klinik für Augenheilkunde

Lübeck, 23538, Germany
Universitätsklinikum Tübingen

Tübingen, 72076, Germany
Universitätsklinikum Ulm

Ulm, 89075, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.